Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Bioanalytical Systems (BASI) Competitors

Bioanalytical Systems logo

BASI vs. AIKI, LUNA, DKDCA, ZJYL, OCX, MBOT, APYX, CLLS, BYSI, and ADAG

Should you be buying Bioanalytical Systems stock or one of its competitors? The main competitors of Bioanalytical Systems include AIkido Pharma (AIKI), Luna Innovations (LUNA), Data Knights Acquisition (DKDCA), Jin Medical International (ZJYL), OncoCyte (OCX), Microbot Medical (MBOT), Apyx Medical (APYX), Cellectis (CLLS), BeyondSpring (BYSI), and Adagene (ADAG).

Bioanalytical Systems vs. Its Competitors

AIkido Pharma (NASDAQ:AIKI) and Bioanalytical Systems (NASDAQ:BASI) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment.

Bioanalytical Systems has higher revenue and earnings than AIkido Pharma. Bioanalytical Systems is trading at a lower price-to-earnings ratio than AIkido Pharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AIkido PharmaN/AN/A-$7.17M-$3.88-1.29
Bioanalytical Systems$60.47M0.37-$4.68M-$0.35-5.74

10.9% of AIkido Pharma shares are held by institutional investors. Comparatively, 10.6% of Bioanalytical Systems shares are held by institutional investors. 8.6% of AIkido Pharma shares are held by company insiders. Comparatively, 11.5% of Bioanalytical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

AIkido Pharma has a net margin of 0.00% compared to Bioanalytical Systems' net margin of -7.75%. AIkido Pharma's return on equity of -18.21% beat Bioanalytical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
AIkido PharmaN/A -18.21% -16.94%
Bioanalytical Systems -7.75%-42.74%-6.38%

In the previous week, AIkido Pharma's average media sentiment score of 0.00 equaled Bioanalytical Systems'average media sentiment score.

Company Overall Sentiment
AIkido Pharma Neutral
Bioanalytical Systems Neutral

AIkido Pharma has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Comparatively, Bioanalytical Systems has a beta of 1.92, suggesting that its share price is 92% more volatile than the S&P 500.

Summary

Bioanalytical Systems beats AIkido Pharma on 6 of the 10 factors compared between the two stocks.

Get Bioanalytical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for BASI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BASI vs. The Competition

MetricBioanalytical SystemsCommercial Physical Research IndustryMedical SectorNASDAQ Exchange
Market Cap$22.37M$28.72M$5.56B$9.09B
Dividend YieldN/AN/A5.06%4.02%
P/E Ratio-4.79N/A28.2620.26
Price / Sales0.370.25408.83152.10
Price / Cash558.4057.2337.1257.67
Price / Book2.910.268.045.49
Net Income-$4.68M-$525K$3.19B$250.45M

Bioanalytical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BASI
Bioanalytical Systems
N/A$2.01
-4.7%
N/A-10.7%$22.37M$60.47M-4.79397
AIKI
AIkido Pharma
N/A$5.10
-3.2%
N/A+159.9%$27.97MN/A-1.314Gap Up
High Trading Volume
LUNA
Luna Innovations
0.3528 of 5 stars
$0.80
-15.8%
N/A-71.3%$27.17M$116.61M0.00390News Coverage
Gap Down
DKDCA
Data Knights Acquisition
N/A$0.55
-12.5%
N/A-44.0%$2.85MN/A-2.902High Trading Volume
ZJYL
Jin Medical International
N/A$0.58
+1.0%
N/A-77.5%$90.96M$23.50M0.00245News Coverage
Positive News
OCX
OncoCyte
1.9143 of 5 stars
$3.18
+16.3%
$6.06
+90.9%
-4.7%$90.80M$3.84M-0.90120
MBOT
Microbot Medical
2.1232 of 5 stars
$2.48
-1.2%
$9.00
+262.9%
+142.6%$90.22MN/A-3.8220Options Volume
APYX
Apyx Medical
2.0359 of 5 stars
$2.37
-8.1%
N/A+52.2%$89.56M$48.10M-4.31270
CLLS
Cellectis
3.4357 of 5 stars
$1.61
+0.6%
$4.00
+148.4%
-23.9%$89.48M$49.22M-1.87290
BYSI
BeyondSpring
N/A$2.21
-2.6%
N/A-1.3%$89.11M$1.75M0.0080
ADAG
Adagene
2.5983 of 5 stars
$1.89
-3.1%
$8.00
+323.3%
-30.8%$89.04M$100K0.00260Gap Up

Related Companies and Tools


This page (NASDAQ:BASI) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners